Nordic Capital and Permira to Acquire Bavarian Nordic for About $3 Billion

Nordic Capital-Led Consortium Takes Inovalon Private

November 24, 2021

Healthcare Services

Inovalon, a cloud-based healthcare data platform provider, was acquired in an all-cash transaction by an equity consortium led by Nordic Capital and joined by Insight Partners, 22C Capital, and Inovalon founder and CEO Keith Dunleavy, M.D., along with certain Class B stockholders. The deal values Inovalon at an enterprise value of about $7.3 billion and provides Inovalon stockholders $41.00 per share in cash to take the company private.

Nordic Capital Acquires Majority Stake in Foxway

June 19, 2023

IT Services

Nordic Capital has signed an agreement to acquire a majority share in Foxway from Norvestor VII and other owners, with completion expected in Q3 2023 subject to customary closing conditions. Nordic Capital will partner with Foxway management and alongside Norvestor to support continued growth, international expansion and Foxway’s focus on circular IT services; Foxway is a Sweden‑headquartered provider of device refurbishment, asset recovery and lifecycle services with over 1,000 employees and SEK ~7.6bn in revenue (2022).

Nordic Capital Acquires Majority Stake in BRP Systems

May 21, 2024

Cloud & SaaS

Nordic Capital has agreed to acquire a majority stake in BRP Systems, a Nordic SaaS ERP platform serving the fitness industry, from Valedo Partners. The partnership with BRP's management will focus on accelerating product development, targeted European expansion and value-accretive add-on acquisitions to support continued growth.

SK Capital to Invest in Swixx BioPharma in Deal Valued at Over €1.5 Billion

December 15, 2025

Healthcare Services

SK Capital Partners, through an affiliate, reached a definitive agreement to invest in Swixx BioPharma AG as the company looks to accelerate its next phase of growth and global expansion. The transaction values Swixx at more than €1.5 billion, with Swixx co-founders and CEO/CFO retaining significant ownership and existing investors HBM Healthcare Investments and Mérieux Equity Partners remaining shareholders.

Novartis to Acquire MorphoSys in $2.9 Billion Deal

February 7, 2024

Pharmaceuticals

Novartis agreed to a voluntary public takeover offer to acquire MorphoSys AG for €68 per share, valuing the deal at about €2.7 billion (reported as $2.9 billion). The acquisition is intended to expand and complement Novartis’ oncology pipeline, including pelabresib (CPI-0610) and tulmimetostat (CPI-0209).

Apax Funds Takes Norva24 Group AB Private

May 19, 2025

Infrastructure

Apax Funds (acting through Nordahl BidCo AB) completed a recommended cash offer to take Norva24 Group AB (publ) private with acceptance from roughly 98% of shareholders. The transaction follows exits by existing investors including Valedo Partners and Nordstjernan after a period of strong organic growth and more than 50 add-on acquisitions that grew Norva24 to roughly NOK 4bn in revenue.